Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi
Open Access
- 1 June 2003
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (6) , 747-749
- https://doi.org/10.3201/eid0906.030020
Abstract
Streptococcus pneumoniae infections can be prevented by using new conjugate vaccines, but these vaccines have limited serogroup coverage. We report the first serogrouping data from carried and invasive isolates obtained from children and adults in Malawi. The 7-valent vaccine would cover 41% of invasive isolates from children and 25% from adults. A 9-valent vaccine, including types 1 and 5, would cover 66% of invasive isolates from children and 55% from adults.Keywords
This publication has 13 references indexed in Scilit:
- The potential of pneumococcal conjugate vaccines for childrenThe Pediatric Infectious Disease Journal, 2002
- Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survivalAIDS, 2002
- Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trialThe Lancet, 2002
- Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adultsVaccine, 2001
- Bacteraemia and Mortality Among Adult Medical Admissions in Malawi – Predominance of Non-typhi Salmonellae andStreptococcus pneumoniaeJournal of Infection, 2001
- Bacterial Meningitis in Malawian Adults: Pneumococcal Disease is Common, Severe, and SeasonalClinical Infectious Diseases, 2000
- Increased Carriage of Trimethoprim/Sulfamethoxazole‐ResistantStreptococcus pneumoniaein Malawian Children after Treatment for Malaria with Sulfadoxine/PyrimethamineThe Journal of Infectious Diseases, 2000
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part IClinical Infectious Diseases, 2000
- PNEUMOCOCCAL SEROTYPES IN WEST AFRICAThe Lancet, 1980